Calian Group (TSE:CGY – Get Free Report) had its price target increased by equities research analysts at Canaccord Genuity Group from C$63.00 to C$80.00 in a research note issued on Friday,BayStreet.CA reports. Canaccord Genuity Group’s price objective points to a potential upside of 13.31% from the stock’s previous close.
A number of other analysts also recently weighed in on CGY. Desjardins upped their target price on shares of Calian Group from C$59.00 to C$66.00 and gave the stock a “buy” rating in a research report on Thursday, November 27th. Ventum Financial increased their target price on Calian Group from C$62.00 to C$72.00 and gave the company a “buy” rating in a research note on Tuesday, January 27th. Royal Bank Of Canada upped their target price on shares of Calian Group from C$58.00 to C$66.00 and gave the company an “outperform” rating in a research note on Thursday, November 27th. Finally, Canadian Imperial Bank of Commerce boosted their target price on shares of Calian Group from C$65.00 to C$76.00 in a research note on Friday. Six investment analysts have rated the stock with a Buy rating, According to MarketBeat.com, Calian Group presently has an average rating of “Buy” and an average price target of C$74.83.
View Our Latest Stock Report on CGY
Calian Group Stock Performance
Calian Group (TSE:CGY – Get Free Report) last issued its quarterly earnings data on Thursday, February 12th. The company reported C$1.03 earnings per share for the quarter. The firm had revenue of C$208.00 million for the quarter. Calian Group had a return on equity of 3.37% and a net margin of 1.50%. Sell-side analysts expect that Calian Group will post 4.9475219 EPS for the current year.
Key Calian Group News
Here are the key news stories impacting Calian Group this week:
- Positive Sentiment: Record Q1 results — Calian reported C$208M revenue (up ~12% YoY) with margin gains and C$1.03 EPS, and management signaled confident growth on the earnings call; this strengthens the growth narrative driving buying interest. Calian Delivers Record Q1 Revenue and Margin Gains
- Positive Sentiment: Multiple analyst target upgrades — Acumen (to C$85, Buy), Canaccord (to C$80), CIBC (to C$76) and Ventum (to C$82, Buy) raised price targets, signaling broad analyst optimism and providing upward catalyst for the stock. Analyst Ratings Roundup
- Positive Sentiment: Quarterly dividend declared — Board approved a C$0.28 quarterly dividend (annualized yield ~1.6%), with ex-dividend Feb 25 and record Mar 11; supports shareholder return profile and can attract income-minded buyers.
- Neutral Sentiment: Corporate governance update — Shareholders re‑elected the board and named Valerie Sorbie as Chair, which preserves leadership continuity but is unlikely to move the stock materially by itself. Shareholder Meeting Results
- Negative Sentiment: RBC’s moderate target bump to C$60 — Although RBC maintained an “outperform” stance, its target remains well below the current price, indicating at least one major analyst sees less upside and creating potential resistance or caution among some investors. RBC Target Update
Calian Group Company Profile
Calian Group Ltd operates through four segments namely Advanced Technologies, Health, Learning, and Information Technology. It generates maximum revenue from the Health segment. The company serves health, defence, security, aerospace, engineering, AgTech, and IT industries. Its Health segment includes Clinical Services; Nursing Services; Psychological Services and Medical Property Management. The Advanced Technologies segment includes Engineering Solutions and Services; Nuclear and Environmental Services; Satcom; DOCSIS; Electronics Design and Manufacturing and Agricultural Technology.
Further Reading
- Five stocks we like better than Calian Group
- Your Bank Account Is No Longer Safe
- Nvidia CEO Issues Bold Tesla Call
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
- The day the gold market broke
Receive News & Ratings for Calian Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calian Group and related companies with MarketBeat.com's FREE daily email newsletter.
